Since adipocytes are the largest storage depot for energy in the form of TG within the LDs in humans [77], it is reasonable to speculate that apoA5 may also target to adipocytes and regulate intracellular TG storage, providing a potential therapeutic target for obesity. Here, APOA5 is linked to obesity due to melanocortin 4 receptor deficiency.